Podcasts by The Long Run with Luke Timmerman
"The Long Run"
Antarctic explorer Ernest Shackleton, if he were alive, would appreciate biotech. Today’s scientific entrepreneurs must be ready for the “hazardous journey, bitter cold, long months of complete darkness, constant danger, safe return doubtful, honor and recognition in case of success.” Today, the men and women who strive to apply science for the betterment of human health have a historic opportunity. They need stamina, and resilience, to achieve something meaningful. Biotech’s relationship with the society that sustains it has never been more tenuous.
Join host Luke Timmerman for in-depth, thought-provoking conversations with biotech newsmakers pursuing these great opportunities of the 21st century.
Further podcasts by Timmerman Report
Podcast on the topic Wissenschaft
All episodes
Ep109: Derrell Porter on Cell Therapy Commercialization from 2022-02-15T01:51:05
Derrell Porter, CEO of CellEvolve, on a new approach to commercializing cell therapies.
Listen
Ep108: Praveen Tipirneni on Targeting Integrins With Small Molecules from 2022-01-31T17:45:19
Praveen Tipirneni, CEO of Morphic Therapeutic, on targeting integrins with small molecules.
Listen
Ep107: Bassil Dahiyat on Antibody Engineering & Company Building from 2022-01-11T15:45:42
Bassil Dahiyat of Xencor on antibody engineering and company building.
Listen
Ep106: Vineeta Agarwala on Health Data & VC Investing from 2021-12-20T22:23:55
Vineeta Agarwala, general partner with Andreesen Horowitz's bio fund, on investing in therapeutics, diagnostics and digital health.
Listen
Ep105: Nello Mainolfi on Targeted Protein Degraders from 2021-12-06T23:20:48
Nello Mainolfi, CEO of Kymera Therapeutics, on targeted protein degrading small molecule drugs.
Listen
Ep104: Jeff Bluestone on Treg Cell Therapies for Autoimmunity from 2021-12-01T17:47:42
Jeff Bluestone, CEO of Sonoma Biotherapeutics, on engineered T-reg cell therapies for autoimmunity.
Listen
Ep103: Ken Song on Targeted Radiopharmaceuticals for Cancer from 2021-11-23T02:46:06
Ken Song, CEO of RayzeBio, on targeted radiopharmaceuticals for cancer.
Listen
Ep102: David Baltimore Reflects on a Life in Science from 2021-11-08T23:48:12
David Baltimore, professor emeritus at Caltech, reflects on a life in science.
Listen
Ep101: Tony Kulesa on Fostering Founder-Led Biotechs from 2021-10-26T18:17:53
Tony Kulesa of Petri.bio on fostering founder-led biotech companies
Listen
Ep100: Christian Henry on Long Read DNA Sequencing from 2021-10-13T02:12:58
Christian Henry, CEO of PacBio, on long read DNA sequencing applications.
Listen
Ep99: Keolu Fox on genome sequencing of indigenous populations from 2021-09-27T16:38:35
Keolu Fox, assistant professor at UC San Diego, on genome sequencing of indigenous populations.
Listen
Ep98: Mara Aspinall on Diagnostics and COVID-19 from 2021-09-13T00:57:34
Mara Aspinall of Arizona State University on diagnostics and COVID-19.
Listen
Ep97: John Evans on Base Edited Therapeutics from 2021-09-07T18:40
John Evans, CEO of Beam Therapeutics, on base editing technology for therapeutics.
Listen
Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids from 2021-08-09T15:07:01
Ep96: Julie Grant and Sam Blackman on Cancer Drugs for Kids
Listen
Ep95: Sue Desmond-Hellmann on Becoming a Biotech Leader from 2021-07-26T22:16:09
Sue Desmond-Hellmann on becoming a physician-scientist and biotech industry leader.
Listen
Ep94: Jenny Rooke on Investing in Biotech Tools from 2021-07-19T20:19:30
Jenny Rooke of Genoa Ventures on investing in biology & technology.
Listen
Ep93: Jay Bradner & Andy Plump on Mentoring Young Scientists from 2021-06-14T19:32:50
Ep93: Jay Bradner of Novartis & Andy Plump of Takeda on Mentoring Young Scientists
Listen
Ep92: Brad Gray on Spatial Biology from 2021-06-01T17:05:48
NanoString Technologies CEO Brad Gray on tools for spatial biology.
Listen
Ep91: Daphne Zohar on Biotech Entrepreneurship from 2021-05-03T23:38:02
Daphne Zohar, CEO of Puretech Health, on starting biotech companies.
Listen
Ep90: James Sabry on Partnering Amid Scientific Abundance from 2021-04-19T13:58:11
James Sabry, global head of pharma partnering for Roche, on partnering in a time of scientific abundance.
Listen
Ep89: Emily Leproust on DNA Synthesis at Scale from 2021-03-29T21:21:33
Emily Leproust, co-founder and CEO of Twist Bioscience, on DNA Synthesis at Scale
Listen
Ep88: Amy DuRoss on software and logistics for cell and gene therapy from 2021-03-15T19:46:24
Amy DuRoss, CEO of Vineti, on software and logistics for cell and gene therapy.
Listen
Ep87: Bob Nelsen of ARCH Venture Partners on Biotech Investing from 2021-03-01T21:07:18
Bob Nelsen of ARCH Venture Partners on long-term trends in biotech investing.
Listen
Ep86: Sek Kathiresan on a Gene-Edited Single Shot for Heart Disease from 2021-02-09T01:18:32
Sekar Kathiresan, co-founder and CEO of Verve Therapeutics, on a gene edited single shot for cardiovascular disease.
Listen
Ep85: Luhan Yang on CRISPR Editing for Organ Transplants from 2021-01-20T00:04:39
Luhan Yang, CEO of Qihan Bio, on CRISPR editing for organ transplants.
Listen
Ep84: Steve Paul on Treatments for Mental Health from 2020-12-22T19:28:41
Steve Paul, CEO of Karuna Therapeutics, on neuropsychiatric drug development.
Listen
Ep83: David Lee on Impact in Pharmaceuticals from 2020-12-14T22:30:03
David Lee, CEO of Servier Pharma, on a nonprofit model.
Listen
Ep82: Andrew Farnum on Medicines From Unusual Traits from 2020-11-23T23:42:22
Andrew Farnum, CEO of Variant Bio, on drug discovery based on rare genetic traits.
Listen
Ep81: Simba Gill on Microbiome Therapies from 2020-11-12T00:17:33
Simba Gill, CEO of Evelo Biosciences, on microbiome therapies.
Listen
Ep80: Peter Kolchinsky on Pharma's Soul from 2020-10-28T17:05:26
Peter Kolchinsky of RA Capital on making drugs affordable, and keeping incentives for drug discovery.
Listen
Ep79: Daphne Koller on Machine Learning for Drug Discovery from 2020-10-26T22:20:40
Daphne Koller, CEO of insitro, on machine learning for drug discovery
Listen
Ep78: Pearl Huang on Exoneural Cancer Biology from 2020-10-13T00:52:23
Pearl Huang, CEO of Cygnal Therapeutics, on Exoneural Cancer Biology
Listen
Ep77: Jennifer Petter on Drugging RNA Targets from 2020-09-29T00:12:31
Jennifer Petter, CSO of Arrakis Therapeutics, on small molecule drugs for RNA targets
Listen
Ep76: Otello Stampacchia on Becoming a Biotech VC from 2020-09-08T16:49:29
Otello Stampacchia on becoming a biotech venture capitalist.
Listen
Ep75: Rosana Kapeller on Drugging the Repeatome from 2020-08-10T22:28:27
Rosana Kapeller, CEO of ROME Therapeutics
Listen
Ep74: Abe Ceesay's Path to Leadership from 2020-07-21T02:24:08
Abe Ceesay, CEO of Tiburio Therapeutics
Listen
Ep73: Kevin Ness on Digital Genome Engineering from 2020-07-07T01:32:45
Ep73: Kevin Ness on Digital Genome Engineering by Timmerman Report
Listen
Conversation on Race with Ted Love from 2020-06-13T12:39:28
Ted Love, CEO of Global Blood Therapeutics, on Racial Inequity
Listen
Ep71: Andy Plump from 2020-06-10T15:04:43
Takeda R&D president Andy Plump on fighting COVID19 and racism.
Listen
Ep70: Nina Kjellson from 2020-05-26T23:22:58
Nina Kjellson forging a path in biotech venture capital.
Listen
Vaccine Strategy with Larry Corey from 2020-05-14T00:34:58
Ep69 of The Long Run with virologist Larry Corey
Listen
Ep67: George Scangos from 2020-04-17T15:59:44
George Scangos of VIR on neutralizing antibodies for SARS-CoV-2
Listen
Ep65: Alexis Borisy & Melanie Nallicheri from 2020-03-24T00:07:28
Leaders of EQRx, a company aspiring to make novel drugs at low prices.
Listen
Ep64: Isabella de la Houssaye from 2020-03-09T21:36:51
Isabella is a Stage 4 lung cancer patient on a mission.
Listen
Ep63: Jeremy Levin from 2020-02-25T03:28:09
Jeremy Levin, chairman of BIO, on the perilous moment in politics.
Listen
Ep62: Jane Grogan from 2020-02-11T22:32:55
Jane Grogan, CSO of Arsenal Bio, on programmable cell therapies.
Listen
Ep61: Sanjiv Patel from 2020-01-27T18:24:47
Sanjiv Patel, CEO of Relay Therapeutics, computational drug discovery company.
Listen
Ep60: Tim Mayleben from 2020-01-14T01:59:12
Tim Mayleben, CEO of Esperion Therapeutics, on cholesterol-lowering meds.
Listen
Ep59: David Baker from 2019-12-30T18:23:50
David Baker, University of Washington protein designer.
Listen
Ep58: Jigar Raythatha from 2019-12-03T16:19:22
Jigar Raythatha of Constellation Pharma on epigenetic drug development.
Listen
Ep56: Tim Springer from 2019-11-13T00:08:45
Tim Springer of Harvard Medical School on his career in science and biotech.
Listen
Ep55: John Hawkins & Jim Geraghty from 2019-10-29T19:55:38
Discussion on the new Henri Termeer biography.
Listen
Ep54: Aoife Brennan from 2019-10-15T19:50:40
CEO of Synlogic on developing synthetic biology-based drugs.
Listen
Ep52: Bruce Carter from 2019-09-18T02:49:16
Bruce Carter on developing a new tuberculosis drug.
Listen
Ep51: Ted Love from 2019-09-03T17:09:04
Ted Love of Global Blood Therapeutics on a new drug for sickle cell disease
Listen
Ep50: Joel Marcus from 2019-08-20T20:08:17
Joel Marcus, chairman of Alexandria Real Estate Equities, on building in biotech clusters.
Listen
Ep49: Janelle Anderson from 2019-08-08T15:59:11
Janelle Anderson on venture capital and off-the-shelf cell therapy at Century Therapeutics
Listen
Ep48: Cindy Perettie from 2019-07-11T17:20:48
Cindy Perettie of Foundation Medicine on genomic analysis for cancer.
Listen
Ep47: Laura Shawver from 2019-07-02T21:32:10
Laura Shawver on synthetic biology engineering of cancer drugs.
Listen
Ep46: Liz O'Day from 2019-06-12T20:49:16
Liz O'Day on metabolite signatures for predicting cancer drug response.
Listen
Ep45: Jay Bradner from 2019-05-22T15:33:39
Jay Bradner, president of Novartis Institutes for Biomedical Research, on his journey from open biology advocate to pharma leadership.
Listen
Ep44: Sheila Gujrathi from 2019-05-09T00:23:01
Sheila Gujrathi, CEO of Gossamer Bio, immunologic drug developer
Listen
Ep43: Jeff Jonas from 2019-04-24T02:18:32
Sage Therapeutics CEO on psychiatric drug development.
Listen
Ep42: Carolyn Bertozzi from 2019-04-09T19:22:12
Carolyn Bertozzi on becoming a chemical biologist/glycobiologist.
Listen
Ep41: Bob Langer from 2019-03-27T02:14:27
MIT's Bob Langer on his journey in science and entrepreneurship.
Listen
Ep40: Serge Saxonov from 2019-03-13T00:41:47
Serge Saxonov on the single-cell analysis revolution.
Listen
Ep39: Julia Owens from 2019-02-26T22:19:01
Julia Owens on pivoting, more than once, in a biotech startup.
Listen
Ep38: Harlan and Chad Robins (Take 2) from 2019-02-13T02:25:16
The co-founders of Adaptive Biotechnologies on immune sequencing.
Listen
Ep37: Bonnie Anderson from 2019-01-29T22:19:04
Bonnie Anderson of Veracyte on genomic diagnostics.
Listen
Ep36: George Scangos from 2019-01-15T22:10:29
George Scangos on building an infectious disease company
Listen
Ep35: Karen Akinsanya from 2019-01-02T16:25:25
Karen Akinsanya of Schrodinger on computational drug discovery
Listen
Ep33: Krishna Yeshwant from 2018-12-11T20:33:25
Krishna Yeshwant of GV on life at the intersection of tech and biotech.
Listen
Ep31: Julie Sunderland from 2018-11-14T01:17:15
Julie Sunderland on VC investing at the nexus of tech and biotech.
Listen
Ep30: Barbara Weber from 2018-10-31T17:18:21
Barbara Weber on synthetic lethal cancer drug discovery
Listen
Ep29: John Wilbanks from 2018-10-16T17:09:23
John Wilbanks on making it easy to share biological data.
Listen
Ep28: Sabah Oney from 2018-10-02T17:50:38
Sabah Oney on becoming a scientific business executive.
Listen
Ep27: Amy Abernethy from 2018-09-18T18:46:04
Amy Abernethy on making EHRs useful for drug development.
Listen
Ep23: Chris Garabedian from 2018-07-24T21:30:47
Chris Garabedian on the "middle market" of biotech VC.
Listen
Ep21: Tony Coles from 2018-06-21T16:54:55
Tony Coles on neurodegenerative drug discovery and inclusive leadership.
Listen
Ep12: David Schenkein from 2018-02-13T22:55:08
Agios CEO David Schenkein on building a cancer R&D engine to last.
Listen
Ep11: Stephane Bancel from 2018-01-31T02:16:48
Stephane Bancel, CEO of Moderna Therapeutics, on his influences.
Listen
Ep10: Abbie Celniker from 2018-01-16T18:25:09
Abbie Celniker of Third Rock Ventures on her career, and chipping away at gender inequities in biotech.
Listen
Ep8: BioMarin History from 2017-12-20T17:51:51
Daniel Levine & Dan Maher discuss their book "A Rare Breed."
Listen
Ep6: Steve Holtzman from 2017-11-29T01:34
Ep6: Steve Holtzman of Decibel Therapeutics on political activism among biotech CEOs.
Listen
Ep5: Elias Zerhouni from 2017-11-08T16:48:35
Elias Zerhouni, president of R&D at Sanofi, on immigration in science and the importance of government science funding.
Listen
Ep4: Richard Pops from 2017-10-24T22:55:42
Alkermes CEO Richard Pops on fighting the opioid painkiller crisis.
Listen
Ep3: George Yancopoulos from 2017-10-10T16:18:34
Interview with Regeneron president and CSO George Yancopoulos
Listen
Ep2: Katrine Bosley from 2017-09-27T09:39:41
Ep. 2 of The Long Run With Luke Timmerman. Interview with Katrine Bosley, CEO of Editas Medicine.
Listen
Ep1: John Maraganore from 2017-09-13T03:23:54
Ep. 1 of The Long Run, a biotech podcast with Luke Timmerman. Conversation with Alnylam Pharmaceuticals CEO John Maraganore.
Listen